BioXcel Therapeutics, Inc. (BTAI)

NASDAQ: BTAI · IEX Real-Time Price · USD
2.57
-0.18 (-6.39%)
Sep 28, 2023, 11:26 AM EDT - Market open

Ratios and Metrics (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year Current202220212020201920182017
Market Capitalization
756025691,12626360-
Market Cap Growth
-5.82%-49.47%327.27%336.30%--
Enterprise Value
5050233791423218-1
PE Ratio
-0.96-3.63-5.32-13.70-7.99-3.13-
PS Ratio
77.261605.17-----
PB Ratio
13.687.842.575.459.801.55-
P/FCF Ratio
-1.21-4.44-6.89-16.89-9.42-4.36-
P/OCF Ratio
-1.21-4.45-6.92-16.97-9.72-4.47-
EV/Sales Ratio
48.281338.80-----
EV/EBITDA Ratio
-0.87-3.19-3.16-11.15-7.08-0.930.11
EV/EBIT Ratio
-0.87-3.19-3.15-11.13-7.04-0.930.11
EV/FCF Ratio
-1.02-3.71-4.08-13.71-8.30-1.290.23
Debt / Equity Ratio
16.621.220.000.010.04--0.38
Debt / EBITDA Ratio
-0.52-0.60-0.01-0.02-0.03--0.08
Debt / FCF Ratio
-0.61-0.69-0.01-0.02-0.04--0.17
Quick Ratio
3.685.9013.9818.003.839.160.38
Current Ratio
3.986.1714.2118.334.039.260.38
Asset Turnover
0.010.0000000
Interest Coverage
-14.07-19.18-2672.27-3042.30-1647.40--
Return on Equity (ROE)
-309.10%-118.00%-46.40%-59.40%-111.00%-41.30%695.10%
Return on Assets (ROA)
-105.30%-72.90%-43.50%-53.40%-85.20%-38.70%-666.50%
Return on Capital (ROIC)
-243.20%-304.10%1957.30%1131.40%1159.20%869.80%498.20%
Earnings Yield
-253.05%-27.54%-18.80%-7.30%-12.51%-31.91%-
FCF Yield
-200.02%-22.51%-14.52%-5.92%-10.62%-22.93%-
Buyback Yield / Dilution
-4.28%-6.23%-21.63%-33.11%-11.79%-50.45%-2.16%
Total Shareholder Return
-4.28%-6.23%-21.63%-33.11%-11.79%-50.45%-2.16%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).